Search PubMed⌕ Search

Biomedical subjects

W E Reed

Publications and source records attributed to W E Reed.

9 recordsLinked to original sources

The use of drugs in renal failure.

We have tried to emphasize specific variables that impact upon the use of drugs in the patient with renal disease. These variables are complex, often interrelated, and if neglected by the physician will surely lead to unwarranted drug reactions and serious harm to the patient. We have purposely limited the tables of "Selected Pharmacologic Agents" to a few prototypic drugs from each class, emphasizing the newer agents recently introduced in clinical medicine. We strongly recommend that as new drugs are used, the original literature be consulted for verification.

Analgesics↗

Sustained-release procainamide: use of serum concentrations to determine dosage.

The utility of the antiarrhythmic drug procainamide (PA) is limited by the required dosage schedule (every three to four hours). A commercially available, slow release procainamide (P-SR) is recommended to be given every six hours. We compared procainamide capsules (P-Caps) given every four hours with P-SR given every six hours in a crossover study of 12 patients. Doses of P-Caps were chosen to produce a therapeutic result and serum drug concentrations within the therapeutic range. Doses of P-SR were adjusted until serum PA concentrations were similar to those when P-Caps were used. The dosage for P-Caps was 58 mg/kg/day +/- 24.6; P-SR dosage was 53 mg/kg/day +/- 15.18 (mean +/- SD) (P not statistically significant). The PA peak to trough variation for P-Caps was 2.2 micrograms/ml +/- 2.3 and for P-SR 1.5 micrograms/ml +/- 1.4 (P not significant). We conclude that P-SR given every six hours in the same daily dose as PA capsules given every four hours will provide similar therapeutic concentrations with no greater peak to trough variation.

Aged↗

Selling Community General.

As Community General Hospital approaches its thirty-second year of operation, its once bright future appears dim. Public support, medicare cost reimbursement, and private insurance have always been sufficient to keep the facility in reasonable working order. With medicare now using DRGs for determining payments, however, the hospital is being forced to reduce its costs. Complicating matters is the deteriorating physical plant, the growing public concern over hospital operations, the declining census, and competition from a larger, newer, better equipped city hospital. County officials are now faced with a dilemma: issuing bonds to either build a new facility or to renovate the existing structure. If such bonds were issued, the problem then becomes how to repay them. As an alternative, county officials have decided to investigate selling the hospital. The above scenario faces many public hospitals. Sooner or later, public officials will have to consider selling the hospital. This article's purpose is to explore those topics that relate to this decision.

Health Facilities↗

Econotherapeutics.

A program that represents the efforts of a hospital pharmacy management company to control drug costs is described. The program, Econotherapeutics, was developed in response to a changed health care reimbursement system that focused on the costs of products rather than the revenue generated by these products. For antimicrobial agents, a hospital-specific antibiogram is used to encourage cost-effective prescribing. A pharmacist intervention program, medical staff presentations, drug usage evaluation, management systems, and educational programs for pharmacists are all essential parts of the program. Centralized data gathering has allowed cost comparison of specific antimicrobial agents so that differences between variable cost estimates and costs based on actual use can be evaluated. Actual dose and dosage interval were used to calculate average cost per treatment day in a 121-hospital sample. Our cost data support the choice of cefotaxime over ceftriaxone.

Anti-Bacterial Agents↗